Apply till April 23, 2021
location_onFinland-Russia
only 10 participants
Join international
LIFE SCIENCE ACCELERATOR
Russian-Finnish Life Science Park welcomes companies and startups with products and services within professional healthcare & life science industries with a solid problem/solution approach, technical proof-of-concept, scalable business potential and committed teams with business experience or readiness for internationalization.
What are the benefits of participation?
Intensive training programme
Access to interactive themed workshops and experts
Individual coaching
An assigned business coach for each startup to lead the company
Life science networking
Access to scientific, business & partnership networks in Russia & Finland
First class laboratories
Possibility to use laboratories of RFLSP for R&D projects
Pitching sessions
Pitching to the possible investors & clients
International events
Best teams will be invited to key international events
What is the timeline?
Review the key milestones of the project.
April, 2021
1.04-23.04 Application period
30.04. Announcement of accepted companies
May, 2021
1.05-15.05. Company interviews
End of May Online workshop 1
- Medical Device and/or Drug Regulation & QMS Individual company consultation
June, 2021
Early June
Online workshop 2
- Marketing & Business Development
Mid June
Online workshop 3
- Strategic Frameworks & Financial Planning
Individual company consultation
July, 2021
Individual company consultation
August, 2021
Mid August
Online workshop 4
- Protection strategies Individual company consultation
September, 2021
Early September
- Online/onsite workshop 5
- Pitching and workshop 6
September 15-16, 2021
HealthBIO event 15-16 with pitching competition in Turku, Finland
Tailormade company visits in Finland Individual company consultation
Who can participate?
Accelerator welcomes companies and startups with products and services within professional healthcare & life science industries with a solid problem/solution approach, technical proof-of-concept, scalable business potential and committed teams with business experience or readiness for internationalization.
Accelerator participants

Finnadvance Oy
Finnadvance Oy develops disease-on-chip for drug discovery and for research. The chips mimic functions of a human organ and allow for more precise and expedient drug discovery. This lowers costs by reducing the need for animal studies. The chips are used to find potential drug candidates for rare diseases and to study efficacy and response. This work will eventually lead to the development of real personalized medicines.

IRS
The Intervention Radiology Systems (IRS) – the Skolkovo participant, the developer of the stereotaxic holder of a medical product for carrying out low-invasive operations under CT/MRI monitoring . At the moment there is a working prototype of a product which passes clinical tests within scientific work in the Voronezh regional clinical hospital (500 operations a year)

ASPM
ASPM - is a Innovative Company, the leader in the R&D, production and application of thin coatings, which are used to produce multifunctional (anti-ice, anti-corrosion, anti-adhesive, anti-friction, hydrophobic, bactericidal, disinfectant) nanosized films with a thickness from 10-100 nm.
The company has the “Russian Nanoproducts” mark, the certificate of “NanoCertificate”, ISO, “RSt” and also holds patents of the European, EAPO, PCT applications registered with the Trademark Certificates in the RF, EU, WIPO system, is a regular participant international and regional industrial exhibitions, scientific conferences and seminars.

Framebiotek
Framebiotek LLC was founded in 2020 in St-Petersburg, Russia. Framebiotek has a full-cycle platform for the development of innovative and generic / biosimilar products and technologies: from idea and molecule design through the technology scaling up and transfer to the local approval. Framebiotek platform are based on the own capacities and competencies of employees as well as friendly laboratories and centers, which are united together by the universal framework used common tools and values. Framebiotek team members have at least 10-years experience to get a success in product and technology development and most of them have PhD degree in biology, chemistry, technology, project management, etc.

PanDx Inc (Pandica project)
PanDх is a startup from Saint-Petersburg. Our company develops novel medical device - catheter “IsyCath”. It addresses unmet medical needs in treating and diagnosing serious and life-threatening conditions of GI and hepato-biliary systems. It is designed to create an isolated area and a controlled environment in an isolated area of gastrointestinal (GI) tract. At the same time, it maintains the connectivity and function of GI tract.
Frequently Asked Questions
starWhat are the benefits of participation? keyboard_arrow_up
Wide range options just right for your successful company. Specializing in customer experiences & business development and internationalization.
Who can participate?keyboard_arrow_up
Accelerator is for companies dealing with professional healthcare:
- Manufacturers and development of medicines and active ingrediences
- Diagnostic devices and tests (IVD)
- Medical Devices including eHealth
- Service providers (Contract Research Organisations)
What are the selection criterias?keyboard_arrow_up
Basic requirements:
- Companies with products and services within professional healthcare & life science industries
- Scalable business potential with a solid problem/solution -approach
- Differentiation of the technology and / or know-how
- Technological proof-of -concept
- IP (intellectual property) is available and is owned by the company
- Experience or readiness for internationalization
- Truly internationally addressable market
- Committed, coachable team with technological and business experience or readiness to adopt it.
- High quality of Board and/or Advisors
- Financial condition in order to join the accelerator for at least next 6 months
- Client acquisition strategy has successfully been proven
What are the rules?keyboard_arrow_up
Max. 10 companies will be selected on the basis of evaluation of applications.
Selection and approval will be performed by selection board of experts.
Participation is free of charge for the companies.
Participating companies: Finland (min 30%) and Russia (min 30%). Companies from EU are allowed The companies are committed to participate in the couching sessions, workshops, arranged events and visits during the Accelerator phase.
The companies are committed to announce publicly participation in the accelerator and support from Russian-Finnish Life Science project financed by South East Finland-Russia cross border cooperation program following visibility guidelines Participants are committed to follow confidentiality rules and good business conduct practices during participation in the accelerator.
Preferably more than one participant per company should be involved in the Accelerator programme.
Working language is English.
Accelerator awardkeyboard_arrow_up
Max 3 companies will be awarded with free of charge participation (including travel and accommodation costs) in CPhI Worldwide or another the major European Life Science event. Winners will be selected by the board of experts. Final choice of event will be made during acceleration program.
Selection board

Sergey TROSHKOV
Project manager
Russian-Finnish Life Science Park
Expert in startups, cross-border cooperation, internationalization and public funding for innovation companies

Kai LAHTONEN
Senior Advisor
Turku Science Park Ltd
Expert on pharma and pharma related business development, internationalization and corporate management

Teppo LAAKSONEN
Network Manager
Turku Science Park Ltd
Hands-on experience in leading high tech IVD company towards global markets and funding of operations

Hanna HALME
Senior Advisor
Turku Science Park Ltd
Life Science startup coach with expertise in management, quality and regulatory issues

Elena PETROVA
Project director
Russian-Finnish Life Science Park
Distinguished pharmaceuticals industry expert on all aspects from R&D to production

Olga MAKEEVA
Senior advisor
Business Finland / Invest in Finland Russia
Expert in Finnish-Russian cooperation, internationalization, innovative public funding and business development and Startup Permit program